Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT.

N Engl J Med. 2010 Aug 5;363(6):532-41. doi: 10.1056/NEJMoa0906393. Erratum in: N Engl J Med. 2010 Oct 7;363(15):1486.

2.

Management of acute attacks of hereditary angioedema: potential role of icatibant.

Longhurst HJ.

Vasc Health Risk Manag. 2010 Sep 7;6:795-802. Review.

3.

Icatibant for the treatment of hereditary angioedema.

Cole SW, Lundquist LM.

Ann Pharmacother. 2013 Jan;47(1):49-55. doi: 10.1345/aph.1R423. Epub 2012 Dec 18. Review.

PMID:
23249729
4.

Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.

[No authors listed]

Prescrire Int. 2010 Nov;19(110):245-7. Review.

PMID:
21284353
5.

Icatibant for hereditary angioedema.

Gras J.

Drugs Today (Barc). 2009 Dec;45(12):855-64. doi: 1396674/dot.2009.45.12.1424267. Review.

PMID:
20135020
6.

Icatibant as acute treatment for hereditary angioedema in adults.

Farkas H.

Expert Rev Clin Pharmacol. 2016 Jun;9(6):779-88. doi: 10.1080/17512433.2016.1182425. Epub 2016 May 13. Review.

PMID:
27123689
8.

Icatibant in hereditary angioedema: news and challenges.

Bouillet L.

Expert Rev Clin Immunol. 2011 May;7(3):267-72. doi: 10.1586/eci.11.16. Review.

PMID:
21595592
9.

Icatibant: HOE 140, JE 049, JE049.

[No authors listed]

Drugs R D. 2004;5(6):343-8. Review.

PMID:
15563238
10.
11.

Therapeutic potential of icatibant (HOE-140, JE-049).

Cruden NL, Newby DE.

Expert Opin Pharmacother. 2008 Sep;9(13):2383-90. doi: 10.1517/14656566.9.13.2383 . Review.

PMID:
18710362
12.

Icatibant: HOE 140, JE 049, JE049.

[No authors listed]

Drugs R D. 2005;6(4):239-44. Review.

PMID:
15991885
13.

Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.

Charignon D, Späth P, Martin L, Drouet C.

Expert Opin Pharmacother. 2012 Oct;13(15):2233-47. doi: 10.1517/14656566.2012.723692. Epub 2012 Sep 13. Review.

PMID:
22970904
14.

Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies.

Bernstein JA.

Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S41-6. Review.

PMID:
18220151
15.

Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.

Zanichelli A, Mansi M, Periti G, Cicardi M.

Expert Rev Clin Immunol. 2013 May;9(5):477-88. doi: 10.1586/eci.13.22. Review.

PMID:
23634741
16.

Hereditary angioedema: management of laryngeal attacks.

Christiansen SC, Zuraw BL.

Am J Rhinol Allergy. 2011 Nov-Dec;25(6):379-82. doi: 10.2500/ajra.2011.25.3670. Review.

PMID:
22185739
17.

[Prophylactic use of icatibant before tracheal intubation of a patient with hereditary angioedema type III. (A literature review of perioperative management of patients with hereditary angioedema type III)].

Iturri Clavero F, González Uriarte A, Tamayo Medel G, Gamboa Setién PM.

Rev Esp Anestesiol Reanim. 2014 Aug-Sep;61(7):375-81. doi: 10.1016/j.redar.2014.01.011. Epub 2014 Jun 13. Review. Spanish.

PMID:
24931134
18.

Hereditary angioedema: new hopes for an orphan disease.

Reshef A, Leibovich I, Goren A.

Isr Med Assoc J. 2008 Dec;10(12):850-5. Review.

19.

Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema.

Frank MM.

Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S23-9. Review.

PMID:
18220149
20.

The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.

Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M.

Expert Opin Drug Saf. 2015;14(11):1725-36. doi: 10.1517/14740338.2015.1094053. Epub 2015 Oct 1. Review.

PMID:
26429506

Supplemental Content

Support Center